| Name | SARS-CoV-2 nsp13-IN-4 |
|---|
| Description | SARS-CoV-2 nsp13-IN-4 (C4 (d)) is a potent and selective nsp13 helicase small-molecule inhibitor and inhibit the ssDNA+ ATPase activity of nsp13 with an IC50 value of 57 μM. SARS-CoV-2 nsp13-IN-4 is druglike molecule with molecular weight of less than 450Da and can provide a broad-spectrum antiviral effect[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 57 μM (nsp13 ssDNA+ ATPase) [1] |
| In Vitro | SARS-CoV-2 nsp13-IN-4 (C4 (d)) inhibits the ssDNA+ ATPase activity and the ssDNA− ATPase activity of nsp13 with IC50 values of 57 μM and 240 μM, respectively[1]. |
| References |
| Molecular Formula | C20H15BrN4O |
|---|---|
| Molecular Weight | 407.26 |